Sign in
4

Changes in Ownership

Aquestive Therapeutics, Inc. Filed Acc 0001214659-26-006554

Chief Legal Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Zalewski Thomas A. · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-18 Grant or award : show line 1 in the form +100,000 100,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-18 Grant or award : show line 2 in the form Non-Qualified Stock Option (right to buy) +75,000 75,000 D
Loading xslF345X06/marketforms-73026.xml…